Perfecting Mice Models to Better Understand Prostate Cancer

Dr. Jim Xuan (1999, 2000 and 2002 Research Grants)

Mice are an important part of medical research because they are physiologically very similar to humans and have the same cancer incidence (30 per cent).

By creating genetically modified mice that mimic genetic alterations and human disease progression, scientists can test theories of causes and treatment of prostate cancer. The more closely a mouse model mimics human cancer, the faster it will lead to new treatments.

Dr. Jim Xuan has been awarded three Foundation grants for his work with mice models. In addition to developing new mouse models for prostate cancer, they have created a blood biomarker that helps monitor the initiation and progress of cancer in mice. They have also developed new three-dimensional technology that allows researchers to see what is happening inside the mice. Previously, the only way to evaluate effectiveness of therapy was during autopsy. Now researchers can see the effects of their interventions while mouse models are alive.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive